T1	Participants 4 38	ADDITION-Cambridge trial protocol:
T2	Participants 97 166	type 2 diabetes and intensive treatment for screen-detected patients.
T3	Participants 635 688	people with screen-detected diabetes in primary care.
T4	Participants 689 741	63 practices in the East Anglia region participated.
T5	Participants 1093 1154	people aged 40-69 years at high-risk of undiagnosed diabetes.
T6	Participants 2441 2487	individuals with clinically diagnosed diabetes
